...
首页> 外文期刊>RSC Advances >Development of a novel drug-eluting stent consisting of an abluminal and luminal coating layer dual therapy system
【24h】

Development of a novel drug-eluting stent consisting of an abluminal and luminal coating layer dual therapy system

机译:新型药物洗脱支架的开发,该药物洗脱支架由腔内和腔外涂层双重治疗系统组成

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to develop a dual drug-coated stent using a bi-directional coating system. Sirolimus (SRL) was coated onto the abluminal area of the stent to prevent restenosis, and WKYMVm, a peptide for endothelial homing, was coated onto the luminal area of the stent to enhance endothelialization. To verify the bidirectional coating of materials, various morphological analysis was carried out by using optical microscopy, scanning electron microscopy, and fluorescence microscopy. The release velocities of the drugs coated onto the luminal and abluminal surfaces of the stent were investigated by using instruments that mimic the body's circulation system. The proliferation of smooth muscle cells was inhibited by SRL, whereas the proliferation of human umbilical vein endothelial cells was enhanced by WKYMVm. This study demonstrated that it is feasible to separate coating layers of the stent strut with new coating technology for the bi-directional function of drugs.
机译:这项研究的目的是开发使用双向涂层系统的双重药物涂层支架。将西罗莫司(SRL)涂覆在支架的腔内区域以防止再狭窄,并将用于内皮归巢的肽WKYMVm涂覆在支架的腔内区域以增强内皮化。为了验证材料的双向涂覆,通过使用光学显微镜,扫描电子显微镜和荧光显微镜进行了各种形态分析。通过使用模仿人体循环系统的仪器,研究了涂覆在支架内腔和外腔表面的药物的释放速度。 SRL抑制平滑肌细胞的增殖,而WKYMVm增强人脐静脉内皮细胞的增殖。这项研究表明,利用新的涂层技术分离支架撑杆的涂层对于药物的双向功能是可行的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号